Brief Assessment of Cognition in Schizophrenia (BACS)
To assess the aspects of cognition found to be the most impaired and most strongly correlated with outcomes in patients with schizophrenia , especially in clinical trials of cognitive enhancement
Cognitive deficits are a core feature of schizophrenia , account for much of the impaired functioning associated with the disorder and are not responsive to existing treatments. In this review, we first describe the clinical presentation and natural ...
An abbreviated version of the brief assessment of cognition in ...
Introduction The assessment of cognitive function is an important step in evaluating patients with schizophrenia because of the extensive evidence that cognitive impairment is a core feature of schizophrenia 1, as well as a key determinant of functional outcome 2. The Brief Assessment of Cognition in Schizophrenia (BACS) has been developed as a quick and efficient tool for measuring cognition ...
Abstract Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures.
Measuring Cognitive Impairments Associated With Schizophrenia in ...
Cognitive impairment associated with schizophrenia (CIAS) negatively impacts daily functioning, quality of life, and recovery, yet effective pharmacotherapies and practical assessments for clinical practice are lacking. Despite the pivotal progress made with establishment of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB ...
ABSTRACT Schizophrenia is a chronic, severe mental illness that affects cognitive functioning alongside its well-known positive and negative symptoms. Cognitive impairments, including deficits in memory, attention, executive function , and social cognition, significantly impact patients' quality of life and independence, yet remain inadequately addressed in clinical practice. This study aims ...
Brief Assessment of Cognition in Schizophrenia
The Brief Assessment of Cognition in Schizophrenia (BACS; Keefe et al., 2004) was designed for use in schizophrenia clinical trials that preserves the desirable features of the RBANS (Randolph, 1998; Gold et al., 1999; Hobart et al., 1999): brief administration and scoring time, portablity, repeatability, and availability of alternate forms. The resulting battery of neurocognitive tests was ...
Cognitive impairment in schizophrenia represents one of the main obstacles to clinical and functional recovery. This expert group paper brings together experts in schizophrenia treatment to discuss scientific progress in the domain of cognitive impairment to address cognitive impairments and their consequences in the most effective way. We report on the onset and course of cognitive deficits ...
Evidence supporting the use of a brief cognitive assessment in ...
Cognitive impairment in psychosis is associated with significant disability in social and occupational function 1,2,3,4. These impairments are present well before the onset of psychosis, increase ...
A considerable proportion of patients with schizophrenia perform below population norms on standardized neuropsychological tests, and the performance of those performing within normal range is lower than predicted based on parental education. Cognitive impairment predates the onset of psychosis, is ...